Spin-off of Diagnostic Division
Post# of 30028
27. Do you plan to split the therapeutic and the diagnostic division? Do you think it could be a positive operation?
It's a possibility we are considering once LymPro is commercial-stage. We believe there is significant benefit.
So does that it's possible after a CLIA-launch or after FDA approval occurs?